Editorial: Treatment of aspergillosis.
D000336:Aerosols; D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy*; D004640:Emetine / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007454:Iodides / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D008271:Mycetoma / Q000601:surgery; D010866:Natamycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D011379:Prognosis
D000336:Aerosols; D007454:Iodides; D009761:Nystatin; D000666:Amphotericin B; D010866:Natamycin; D004640:Emetine